Albany, NY. Nixon Peabody LLP is proud to be recognized by The M&A Advisor for the firm’s role in the sale of ZyMōt Fertility, Inc., to CooperSurgical, Inc.—which has been selected as a “Healthcare & Life Sciences Deal of the Year.”
A team from Nixon Peabody represented assisted reproductive technology company DxNow, Inc., the owner of ZyMōt Fertility, in the transaction. ZyMōt Fertility—which became a wholly owned subsidiary of CooperSurgical following the transaction—develops, commercializes, manufactures, promotes, markets, and sells a first-of-its-kind sperm separation device for use in artificial or assisted reproductive therapies.
This transaction marked the first end-to-end deal facilitated through the Nixon Peabody’s Women in Dealmaking initiative. Formed in 2021, Women in Dealmaking is a robust national network of dynamic women leaders in M&A and private equity created to establish strong cross-industry connections, capitalize on new business opportunities, and elevate the voices of women in these spaces to increase equity and impact in a space long dominated by men.
“This transaction highlights the impactful work Nixon Peabody’s Women in Dealmaking network strives to achieve,” said Corporate partner Marissa Wiley, who led the firm’s deal team and co-leads the firm’s Women in Dealmaking initiative. “We are honored to have played a role in supporting one of the healthcare and life sciences industries’ most notable transactions of the year. Congratulations to all of this year’s winners.”
In addition to Wiley, the Nixon Peabody deal team included partners Amy O’Keefe, Shahzad Malik, Thomas McCord, Todd Tidgewell, and Hannah Bornstein; counsel David Crosby, Michael Fitzpatrick, Rachel Pugliese, and Christopher Stevens; associates Carolyn Glynn, Kelly Glynn, Yasmin Hayre, and Robert Pethick; and paralegal Delaney Jaffarian.
Honorees of the 16th Annual International M&A Awards will be honored at the 2025 Leadership in Dealmaking Summit on September 15 and 16 in New York City.
To learn more about the transaction, read Nixon Peabody's press release.
